General form of registration statement for all companies including face-amount certificate companies

SEGMENT REPORTING (Details) - Schedule of segment reporting information, by segment

v3.21.2
SEGMENT REPORTING (Details) - Schedule of segment reporting information, by segment - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Mar. 31, 2020
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Dec. 31, 2019
Segment Net Sales:              
Total Net Sales $ 3,672 $ 1,939   $ 7,149 $ 4,853 $ 12,117 [1] $ 7,834
Segment Profit (Loss):              
Gross profit 2,334 907   4,565 3,068 7,413 [1] 3,102
Non-cash share based compensation       (4,873) (713) (1,652) [2] (1,522) [2]
Depreciation and amortization (524) (365)   (1,103) (717) (1,854) [1] (1,480)
Goodwill impairment       (1,682) (1,682) [1],[2] [2]
Loss from operations 9,603 7,325   17,371 16,499 28,528 [1] 36,540
Loss on debt extinguishment [2]           (2,360) (3,374)
Gain on remeasurement of warrant liability (1,176)     3,675 (10,780) [1]
Loss on fair value of derivative instrument   (13)     657 [1] 421
Loss on investments   67   228 464 [1] 756
Foreign exchange loss 80 311   839 359 491 [1] 1,575
Interest expense 920 953   1,898 1,789 4,455 [1] 2,684
Miscellaneous, net (485) 105   (1,087) 48 (284) [1] 534
Operating Segments              
Segment Net Sales:              
Total Net Sales 3,672 1,939   7,149 4,853 12,117 7,834
Segment Profit (Loss):              
Gross profit (2,970) (4,521)   (5,222) (9,442) (16,935) (24,636)
Long-lived assets              
Long-lived assets 28,704     28,704   25,680 24,432
Reconciliation              
Segment Profit (Loss):              
Gross profit (2,970) (4,521)   (5,222) (9,442) (16,935) (24,636)
Unallocated corporate expenses           (6,405) (5,887)
Non-cash share based compensation 3,323 297   4,873 713 (1,652) (1,522)
Depreciation and amortization 524 365   1,103 717 (1,854) (1,480)
Herbal Brands acquisition related charges           (3,015)
Goodwill impairment         1,682 (1,682)
Loss from operations 9,603 7,325   17,371 16,499 (28,528) (36,540)
Loss on debt extinguishment           2,360 3,374
Loss on fair value of derivative instrument   (13)       657 421
Loss on investments   67     228 464 756
Foreign exchange loss 80 311   839 359 491 1,575
Interest expense           4,455 2,684
Miscellaneous, net           (284) 534
Loss from operations before income taxes 2,786 2,141   6,173 3,945 (25,891) (45,884)
Cannabinoid              
Segment Profit (Loss):              
Goodwill impairment            
Cannabinoid | Operating Segments              
Segment Net Sales:              
Total Net Sales 579 153   1,256 395 2,511 133
Segment Profit (Loss):              
Gross profit (3,604) (4,454)   (6,468) (9,855) (18,798) (25,250)
Long-lived assets              
Long-lived assets 28,528     28,528   25,485 24,209
Non-Cannabinoid              
Segment Profit (Loss):              
Goodwill impairment     $ (1,682) (1,682)   (1,682)  
Non-Cannabinoid | Operating Segments              
Segment Net Sales:              
Total Net Sales 3,093 1,786   5,893 4,458 9,606 7,701
Segment Profit (Loss):              
Gross profit 634 $ (67)   1,246 $ 413 1,863 614
Long-lived assets              
Long-lived assets $ 151     $ 151   176 207
Other | Operating Segments              
Long-lived assets              
Long-lived assets           $ 19 $ 16
[1] See Note 3. for information on the restatement adjustment as of December 31, 2020.
[2] See Note 3. for information on the restatement adjustment as of December 31, 2020 and on the reclassification adjustment as of December 31, 2019.